Developer docs
API playgroundTry for free, no card

Search company profiles

Cannarma

Full company profile

uuid000etmq

Namestring
Cannarma
Legal namestring
Cannarma
Websiteurl
cannarma.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Cannarma is a privately held Indian medicinal cannabis and Ayurvedic-hemp wellness startup, incorporated in the 2023 timeframe and incubated at Amity Innovation Incubator in Noida, with a Delhi-centered operating footprint. The company blends classical Ayurvedic Vijaya (Cannabis sativa) formulations with modern CO2-extracted full-spectrum hemp extracts to manufacture and sell AYUSH-licensed products across pain management, sleep, anxiety, skincare, haircare, sexual wellness, and respiratory health. Its core technology is a CO2 extraction process applied to hemp grown in the USA and ethically sourced raw materials from the Himalayan region, packaged into a 19-SKU catalog anchored by three strengths of full-spectrum Hemp Extract CBD Oil (500mg, 1500mg, 3000mg) and an Ayurvedic flagship, Trailokya Vijaya Vati.

The business model is direct-to-consumer e-commerce through cannarma.com, supplemented by marketplace listings on Amazon India, Tata 1mg, and Healthkart, and physical distribution via Apollo Pharmacy with stated expansion into medical stores, clinics, and hospitals. Pricing is one-time (pay-as-you-go) and ranges from Rs 98 for a 30ml Ayurvedic cough syrup to Rs 5,999 for the highest-strength CBD oil, with free shipping above Rs 1,200 and a 10% newsletter-acquisition discount. Customer segments are horizontal rather than enterprise-led: health-conscious consumers with chronic pain, anxiety and sleep conditions are the primary use case, with secondary segments in Ayurvedic wellness consumers and medical patients under supervision for serious conditions (e.g., cancer pain, chemotherapy side effects). The company claims 15,000+ customers globally and monetizes an add-on medical consultation service with certified Ayurvedic experts.

Cannarma is venture-backed at the pre-seed stage following a November 2023 round led by Zero to One Fund with Amity Innovation Incubator, at a Rs 17 crore (~$2.04M) pre-money valuation, with a follow-on round led by Zero to One Fund in November 2024. Capital is being deployed for India distribution expansion, product development, and preparation for international market entry. The company holds AYUSH licensing from the Department of AYUSH, Government of India, which is treated as the central regulatory asset and key barrier to entry, but it discloses no patents, no AI/ML capabilities, and no revenue figure.

Short descriptiontext

Cannarma is an Indian AYUSH-licensed startup selling full-spectrum CBD oils, Ayurvedic Vijaya formulations, and hemp-derived wellness products D2C and via Amazon, Tata 1mg, Healthkart, and Apollo Pharmacy. It targets Indian consumers managing chronic pain, anxiety, sleep conditions, and general wellness under Ayurvedic principles.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDelhi, India
HQ citystring
Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ayurvedic hemp products, cbd wellness oils, hemp extract supplements, medicinal cannabis, ayurvedic pain relief
Industry3 codes
1CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles)
CodeCRANAHAAPrimaryYes
2Herbal & Botanical Supplements
CodeCRADAGADPrimaryNo
3Ayurveda & Traditional Healing (Ayurvedic Retreats, Panchakarma, Herbal Therapies)
CodeTHAJAHAEPrimaryNo
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Ayurvedic Medicinal Cannabis Products
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1E-commerce Product Sales
TypeOne Time License
Description

Direct-to-consumer sales of hemp and CBD wellness products through their e-commerce platform and third-party marketplaces. One-time purchase model with products ranging from ₹98 to ₹5,999.

cannarma.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Supply Chain, Operations, Personnel, Marketing or Sales
Pricing details3 tiers
1Entry-level CBD products for new users
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Trailokya Vijaya Vati ₹229, Hemp Pain Relief Roll On ₹206, Cough Syrup 30ml ₹98

cannarma.com
2Mid-range wellness products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Hemp Pain Relief Massage Oil ₹379, Hemp Hair Oil ₹305, Hemp Seed Oil ₹404

cannarma.com
3Premium CBD oils for therapeutic use
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Hemp Extract CBD Oil 500mg ₹2,749, 1500mg ₹3,949, 3000mg ₹5,999

cannarma.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Cannarma manufactures and sells Ayurvedic hemp and CBD-based wellness products, including oils, topicals (balms), skincare, and dietary supplements, formulated using CO2-extracted full-spectrum hemp. The company holds manufacturing and product licenses issued by the Department of AYUSH, Government of India, and markets its products to Indian consumers seeking natural, plant-based wellness remedies rooted in traditional Ayurvedic medicine.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Products used by 15,000+ customers globally
Product overview1 text field

Cannarma is an Ayurvedic hemp and CBD wellness company offering a diverse portfolio of hemp-derived and traditional Ayurvedic products. The core offerings center on full-spectrum CBD oils available in three strengths (500mg, 1500mg, 3000mg) for anxiety, sleep, and pain management. Complementary product lines include topical pain relief solutions (massage oils, balms, roll-ons), skincare (face oils, aloe vera gel, rose water), hair care (hair oil), nutritional supplements (hemp seed oil, Shilajit, Manmath Ras, Laxmi Vilas Ras), healthcare (cough syrups), and beverages (hemp coffee). The company blends ancient Ayurvedic principles (Vijaya-based formulations) with modern science, all products are AYUSH-compliant and lab-tested. A medical consultation service provides expert guidance on product usage.

Product and service4 records
1Cannarma CBD Oils
CategoryCBD Wellness Oils
Description

CO2-extracted full-spectrum Ayurvedic hemp oils sold to Indian consumers seeking natural wellness support for issues such as pain, sleep, and anxiety.

2Cannarma Topicals and Balms
CategoryCBD Topicals and Balms
Description

Ayurvedic hemp and CBD topicals, including balms and creams, designed for localized application to support relief from pain, inflammation, and skin discomfort.

3Cannarma Skincare
CategoryCBD Skincare
Description

Hemp and CBD-infused skincare products positioned within Cannarma's Ayurvedic wellness range for consumers seeking natural skin health solutions.

4Cannarma Hemp Dietary Supplements
CategoryHemp Supplements
Description

Hemp-based dietary supplements sold as part of Cannarma's Ayurvedic wellness catalog for consumers seeking ingestible plant-based wellness options.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

India's first and most prominent industrial hemp and medicinal cannabis company, selling BOHECO Hemp wellness products (oils, topicals, supplements). Closest direct competitor to Cannarma in the Indian AYUSH-aligned hemp/CBD space.

TypeDirect peer
Description

Indian Ayurvedic cannabis (Vijaya) wellness brand selling full-spectrum CBD oils, topicals, and capsules directly to consumers — overlapping product mix, regulatory framework (AYUSH), and target customer.

TypeDirect peer
Description

India-based hemp wellness brand selling hemp seed foods, oils, and CBD products through D2C e-commerce — directly comparable D2C hemp-wellness model targeting Indian health-conscious consumers.

TypeDirect peer
Description

Indian hemp and CBD product company offering oils, topicals, and capsules with a similar Ayurvedic wellness positioning and D2C-led distribution.

TypeBroad incumbent
Description

Largest Indian Ayurvedic FMCG brand with extensive herbal wellness portfolio and massive distribution. Competes for the same Ayurvedic-wellness consumer wallet Cannarma targets, though without a dedicated cannabis/CBD line.

TypeBroad incumbent
Description

Established Indian herbal healthcare and personal-care company with nationwide pharmacy and retail presence — competes in the herbal wellness category Cannarma addresses and dominates shelf space Cannarma would need to win.

TypeBroad incumbent
Description

Largest US-based hemp CBD wellness brand, offering full-spectrum CBD oils, topicals, and pet products. Comparable product architecture, D2C channel, and 'premium natural' positioning, though in a far more mature regulatory market.

TypeEmerging player
Description

Indian Ayurvedic aromatherapy and wellness brand selling oils, skincare, and hemp-based products through D2C. Overlaps Cannarma in the hemp-skincare and Ayurveda-meets-modern-wellness positioning.

TypeEmerging player
Description

US-listed hemp CBD consumer-products company selling PlusCBD Oil and topical brands. Useful comparable for full-spectrum CBD product portfolio economics and D2C-plus-retail channel mix.

TypeBroad incumbent
Description

Global cannabis major with consumer wellness, medical, and hemp-CPG divisions. Demonstrates the long-term global cannabis-wellness category economics Cannarma could participate in if it successfully executes an India-plus-global strategy.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cannarma

Ayurvedic Medicinal Cannabis Productscannarma.com

Cannarma is an Indian AYUSH-licensed startup selling full-spectrum CBD oils, Ayurvedic Vijaya formulations, and hemp-derived wellness products D2C and via Amazon, Tata 1mg, Healthkart, and Apollo Pharmacy. It targets Indian consumers managing chronic pain, anxiety, sleep conditions, and general wellness under Ayurvedic principles.

What Cannarma does

Cannarma is a privately held Indian medicinal cannabis and Ayurvedic-hemp wellness startup, incorporated in the 2023 timeframe and incubated at Amity Innovation Incubator in Noida, with a Delhi-centered operating footprint. The company blends classical Ayurvedic Vijaya (Cannabis sativa) formulations with modern CO2-extracted full-spectrum hemp extracts to manufacture and sell AYUSH-licensed products across pain management, sleep, anxiety, skincare, haircare, sexual wellness, and respiratory health. Its core technology is a CO2 extraction process applied to hemp grown in the USA and ethically sourced raw materials from the Himalayan region, packaged into a 19-SKU catalog anchored by three strengths of full-spectrum Hemp Extract CBD Oil (500mg, 1500mg, 3000mg) and an Ayurvedic flagship, Trailokya Vijaya Vati.

The business model is direct-to-consumer e-commerce through cannarma.com, supplemented by marketplace listings on Amazon India, Tata 1mg, and Healthkart, and physical distribution via Apollo Pharmacy with stated expansion into medical stores, clinics, and hospitals. Pricing is one-time (pay-as-you-go) and ranges from Rs 98 for a 30ml Ayurvedic cough syrup to Rs 5,999 for the highest-strength CBD oil, with free shipping above Rs 1,200 and a 10% newsletter-acquisition discount. Customer segments are horizontal rather than enterprise-led: health-conscious consumers with chronic pain, anxiety and sleep conditions are the primary use case, with secondary segments in Ayurvedic wellness consumers and medical patients under supervision for serious conditions (e.g., cancer pain, chemotherapy side effects). The company claims 15,000+ customers globally and monetizes an add-on medical consultation service with certified Ayurvedic experts.

Cannarma is venture-backed at the pre-seed stage following a November 2023 round led by Zero to One Fund with Amity Innovation Incubator, at a Rs 17 crore (~$2.04M) pre-money valuation, with a follow-on round led by Zero to One Fund in November 2024. Capital is being deployed for India distribution expansion, product development, and preparation for international market entry. The company holds AYUSH licensing from the Department of AYUSH, Government of India, which is treated as the central regulatory asset and key barrier to entry, but it discloses no patents, no AI/ML capabilities, and no revenue figure.

Cannarma firmographics

Firmographics
Name
Cannarma
Legal name
Cannarma
Website
https://cannarma.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Cannarma is an Indian AYUSH-licensed startup selling full-spectrum CBD oils, Ayurvedic Vijaya formulations, and hemp-derived wellness products D2C and via Amazon, Tata 1mg, Healthkart, and Apollo Pharmacy. It targets Indian consumers managing chronic pain, anxiety, sleep conditions, and general wellness under Ayurvedic principles.
Ownership category
akta.pro rank

Cannarma industry classification

Industry
Product category
Ayurvedic Medicinal Cannabis Products
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833), Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro primary industry
CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles) (CRANAHAA)
akta.pro secondary industries
Herbal & Botanical Supplements (CRADAGAD), Ayurveda & Traditional Healing (Ayurvedic Retreats, Panchakarma, Herbal Therapies) (THAJAHAE)

Keywords

  • Ayurvedic hemp products
  • Cbd wellness oils
  • Hemp extract supplements
  • Medicinal cannabis
  • Ayurvedic pain relief

Where Cannarma is headquartered

Location

Headquarters

HQ city
Delhi
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Cannarma business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales

Revenue model

  1. E-commerce Product Sales: Direct-to-consumer sales of hemp and CBD wellness products through their e-commerce platform and third-party marketplaces. One-time purchase model with products ranging from ₹98 to ₹5,999.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goEntry-level CBD products for new users
Unit PricingPay-as-you-goMid-range wellness products
Unit PricingPay-as-you-goPremium CBD oils for therapeutic use

Go-to-market motion1 record

Distribution channels6 records

Marketing channels4 records

Cannarma product offering

Product offering

Core offering

Cannarma manufactures and sells Ayurvedic hemp and CBD-based wellness products, including oils, topicals (balms), skincare, and dietary supplements, formulated using CO2-extracted full-spectrum hemp. The company holds manufacturing and product licenses issued by the Department of AYUSH, Government of India, and markets its products to Indian consumers seeking natural, plant-based wellness remedies rooted in traditional Ayurvedic medicine.

Product overview

Cannarma is an Ayurvedic hemp and CBD wellness company offering a diverse portfolio of hemp-derived and traditional Ayurvedic products. The core offerings center on full-spectrum CBD oils available in three strengths (500mg, 1500mg, 3000mg) for anxiety, sleep, and pain management. Complementary product lines include topical pain relief solutions (massage oils, balms, roll-ons), skincare (face oils, aloe vera gel, rose water), hair care (hair oil), nutritional supplements (hemp seed oil, Shilajit, Manmath Ras, Laxmi Vilas Ras), healthcare (cough syrups), and beverages (hemp coffee). The company blends ancient Ayurvedic principles (Vijaya-based formulations) with modern science, all products are AYUSH-compliant and lab-tested. A medical consultation service provides expert guidance on product usage.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cannarma CBD Oils CO2-extracted full-spectrum Ayurvedic hemp oils sold to Indian consumers seeking natural wellness support for issues such as pain, sleep, and anxiety.
  • Cannarma Topicals and Balms Ayurvedic hemp and CBD topicals, including balms and creams, designed for localized application to support relief from pain, inflammation, and skin discomfort.
  • Cannarma Skincare Hemp and CBD-infused skincare products positioned within Cannarma's Ayurvedic wellness range for consumers seeking natural skin health solutions.
  • Cannarma Hemp Dietary Supplements Hemp-based dietary supplements sold as part of Cannarma's Ayurvedic wellness catalog for consumers seeking ingestible plant-based wellness options.

Quantifiable outcome

  • Products used by 15,000+ customers globally

Companies that use Cannarma

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Cannarma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Cannarma partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Cannarma competitors and assessment

Company assessment

Direct peers

  • Bombay Hemp Company (BOHECO): India's first and most prominent industrial hemp and medicinal cannabis company, selling BOHECO Hemp wellness products (oils, topicals, supplements). Closest direct competitor to Cannarma in the Indian AYUSH-aligned hemp/CBD space.
  • Awshad: Indian Ayurvedic cannabis (Vijaya) wellness brand selling full-spectrum CBD oils, topicals, and capsules directly to consumers — overlapping product mix, regulatory framework (AYUSH), and target customer.
  • Hempsters: India-based hemp wellness brand selling hemp seed foods, oils, and CBD products through D2C e-commerce — directly comparable D2C hemp-wellness model targeting Indian health-conscious consumers.
  • Hemplanet: Indian hemp and CBD product company offering oils, topicals, and capsules with a similar Ayurvedic wellness positioning and D2C-led distribution.

Broad incumbents

  • Patanjali Ayurved: Largest Indian Ayurvedic FMCG brand with extensive herbal wellness portfolio and massive distribution. Competes for the same Ayurvedic-wellness consumer wallet Cannarma targets, though without a dedicated cannabis/CBD line.
  • Himalaya Wellness: Established Indian herbal healthcare and personal-care company with nationwide pharmacy and retail presence — competes in the herbal wellness category Cannarma addresses and dominates shelf space Cannarma would need to win.
  • Charlotte's Web Holdings: Largest US-based hemp CBD wellness brand, offering full-spectrum CBD oils, topicals, and pet products. Comparable product architecture, D2C channel, and 'premium natural' positioning, though in a far more mature regulatory market.
  • Tilray Brands: Global cannabis major with consumer wellness, medical, and hemp-CPG divisions. Demonstrates the long-term global cannabis-wellness category economics Cannarma could participate in if it successfully executes an India-plus-global strategy.

Emerging players

  • Soulflower: Indian Ayurvedic aromatherapy and wellness brand selling oils, skincare, and hemp-based products through D2C. Overlaps Cannarma in the hemp-skincare and Ayurveda-meets-modern-wellness positioning.
  • CV Sciences: US-listed hemp CBD consumer-products company selling PlusCBD Oil and topical brands. Useful comparable for full-spectrum CBD product portfolio economics and D2C-plus-retail channel mix.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Cannarma social profiles

Digital presence

Cannarma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cannarma leadership team

Management profile

Number of profiles

Profiles2 records

Cannarma funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cannarma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cannarma

What does Cannarma do?

Cannarma manufactures and sells Ayurvedic hemp and CBD-based wellness products, including oils, topicals (balms), skincare, and dietary supplements, formulated using CO2-extracted full-spectrum hemp. The company holds manufacturing and product licenses issued by the Department of AYUSH, Government of India, and markets its products to Indian consumers seeking natural, plant-based wellness remedies rooted in traditional Ayurvedic medicine.

Is Cannarma a public or private company?

Cannarma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cannarma founded?

Cannarma was founded in 2023. It employs 11 to 50 people.

Where is Cannarma based?

Cannarma is headquartered in Delhi, India, in the Asia region.

How does Cannarma make money?

One revenue line is on record: E-commerce Product Sales.

Who are Cannarma's main competitors?

Direct peers on record are Bombay Hemp Company (BOHECO), Awshad, Hempsters and Hemplanet. Broad incumbents are Patanjali Ayurved, Himalaya Wellness, Charlotte's Web Holdings and Tilray Brands. Emerging players are Soulflower and CV Sciences.

Does Cannarma have an API?

No public API is recorded for Cannarma.

What industry is Cannarma in?

Cannarma's product category is Ayurvedic Medicinal Cannabis Products. Its primary akta.pro industry code is CRANAHAA, CBD/Hemp Specialty Stores (Tinctures, Oils, Edibles), with a secondary code of CRADAGAD, Herbal & Botanical Supplements. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The WeekCannarma raises undisclosed money from Zero to One Fund at pre-money Valuation of ₹ 17 crore 2.04 million to diversify hemp product lineCannarma has raised an undisclosed amount from Zero to One Fund at a pre-money valuation of ₹ 17 crore ($2.04 million) to diversify its hemp product line. The funds will be used for growth initiatives including customer engagement and expansion into new geographies, with plans for global market entry by the next financial year. Cannarma aims to capitalize on the growing trend towards alternative medicine and has a total addressable market size of over $146.4 billion.Financial ExpressMedicinal cannabis startup Cannarma raises funding from Zero to One fundMedicinal cannabis startup Cannarma secured undisclosed funding from the early-stage venture capital fund Zero to One at a pre-money valuation of Rs 17 crore. The company intends to utilize these funds to expand its distribution network across more than 10,000 medical outlets in India and initiate international expansion by the next financial year.EntrackrMedicinal cannabis startup Cannarma raises pre-seed roundMedicinal cannabis startup Cannarma has raised an undisclosed pre-seed investment led by Praveen Kaushik of Zero to One Fund, with additional backing from Amity Innovation Incubator. The company plans to utilize the funds for customer engagement, technological development, and expansion into over 10,000 medical stores, clinics, and hospitals across India.